With the 2017 PGA Merchandise Show just around the corner, Cure Putters reported on its growth and record setting sales in 2016. Cure gained significant traction on Tour in 2016 with putters in play on the PGA, LPGA, Champions Tour, European Tour, Web.com and PGA Tour Latino America. Over 60 Tour professionals put a Cure Putter in play in 2016, resulting in 3 wins and 22 Top 10 finishes. Cure expanded domestic and international business for a 400% increase in total sales in 2016.
“2016 was an incredibly successful year for us,” said CEO of Cure Putters, Jim McCarthy, “Cure Putters has redefined the category of High MOI putters and the golf industry has taken notice. We’re seeing a shift in the industry with more high MOI putters being introduced and we’ve been on the forefront, leading the charge since we launched in 2014. We’ve come a long way since we started and with the feedback of our Tour players and customers we’ve made drastic improvements to the designs of our putters each year, all the while remaining true to our core belief that “form follows function” and that the combination of Extremely High MOI plus a wide range of weight adjustability delivers real, measurable improvement. Player stats and extensive lab testing has proven that our tech works! Like I’ve said before, this isn’t a trend…it’s a Revolution! Our 2017 line up represents our best work to date and we look forward to introducing the latest RX and Classic series putters at the PGA show.”
Cure Putters will be exhibiting in Booth #801 at the 2017 PGA Merchandise Show, scheduled for January 25-27th, at the Orange County Convention Center in Orlando, Florida as well as participating in the Demo Day, Tuesday, January 24th at Orange County National.
Cure Putters, “The Fastest Growing Putter on The Champions Tour”, announced today that they will be exhibiting in Booth #801 at the 2017 PGA Merchandise Show, scheduled for January 25-27th, at the Orange County Convention Center in Orlando, Florida as well as participating in the Demo Day, Tuesday, January 24th at Orange County National GC.
Cure will be showcasing their new 2017 RX and Classic Series putters, including their new CX3 Mallet. Cure will also be exhibiting a sample of custom offerings that will be made available through their custom shop later in the year.
“We are extremely proud and excited to introduce our 2017 line up at the PGA show,” said Jim McCarthy, Cure CEO. “We have the best R&D team in the business and they are always looking for new ways to raise the bar and we’ve been fortunate to work with a ton of tour players on the PGA, LPGA and Champions Tour this year who believe in our technology. We have also tested thousands of amateur players and all of the groups of have given us some valuable feedback which allowed us to fine tune certain aspects of our designs and further expand our offering to meet the needs of a wider range of players. We're thrilled with what has come out of that process and can't wait to share it with the world.”
About the CX3 Classic Series
The CX3 mallet is the newest evolution of the award winning Cure Classic Series line. The CX3 offers a traditional mallet shape with Extremely High MOI and 48g of weight adjustability via 8 removable, 6g weight screws. The CX3 can be set up between 360 - 408g with an impressive MOI of 6,950 - 8,200 g/cm2.
The head is 100% precision milled in the USA from aircraft grade aluminum and has large tungsten weights in the heel and toe, giving the slightly oversized profile a higher MOI than comparable mallets, adding tremendous stability throughout the stroke and incredible forgiveness on mishits. The CX3 is available in both center shafted and heel shafted versions and is face balanced with 2.5° of loft and a spiral milled face that delivers a great feel and excellent roll.
About the 2017 RX Series – RX3, RX4, RX5
The 2017 Cure RX Series has extremely High MOI (up to 18,000 g/cm2), which delivers incredible stability throughout your stroke, helps you square the putter at impact and offers unmatched forgiveness on mishits. This translates to better distance and directional control and improved consistency. Fully customizable with a wide range of both weight and lie adjustability, you can easily dial in the perfect fit and feel to suit your stroke and tempo. The 2017 RX Series features an updated look with new alignment lines and black hardware.
Cure Putters is saddened to report that its Vice President of Tour Operations, Jim Barfield, passed away at his home in Heathrow, Florida on Saturday, December 10th. Barfield had just celebrated his 73rd birthday in November. Barfield leaves behind his wife, Loretta, his four sons and their families, as well as a sister.
Jim Barfield was a key member of the Cure Putters team in his role as the Vice President of Professional Tour Operations. He worked primarily out on the Champions Tour but also helped with the strategic planning and the product road map for the entire company. Prior to joining Cure Putters, Barfield was the CEO of Rife Putters and enjoyed much success there as well.
Prior to his successful business career, Jim was an All-American baseball player at Auburn University and was drafted by the Brooklyn Dodgers in 1964. He still holds the highest career batting average (.385) in Auburn history. Jim played professional baseball for a while and ultimately ended up playing some professional golf as well.
"We would like to thank Jim for all of his contributions to Cure Putters and I would personally like to thank him for his friendship,” said Jim McCarthy, CEO of Cure Putters. “He was a great athlete but an even better man, husband, father, friend and colleague. He will be sorely missed by all who knew him.”
A growing number of Professionals on the PGA, LPGA and Champions Tour are choosing to put a Cure Putter into play each week. Cure Putters success on the professional golf tours continued this past weekend in Daytona Beach, Florida.
Using a Cure RX5 Putter, Jaye Marie Green buried a 20 foot birdie putt on the 90th and final hole to win the LPGA Tour Qualifying Tournament on Sunday. Green became the first player to win the event twice since it moved to Daytona Beach in 1991. In 2013, she won with a record score of 29 under. Green finished at 13-under and captured a one stroke victory at LPGA International. This win at Q-School earns her a full exemption on the LPGA Tour for 2017.
"I feel really good about it, and the bye weeks leading up I wasn't really that nervous, which is weird," Green said. "I was really laid back this week, and I felt like I was picking up where I left off from three years ago."
“We’d like to congratulate Jaye on her win this past week. She’s an incredibly talented player and we’re extremely proud and honored to have her rolling a Cure putter,” said Jim McCarthy, CEO of Cure Putters. “We look forward to following her success on the LPGA Tour in 2017 and wish her all the best.”
A growing number of Professionals on the PGA, LPGA and Champions Tour are choosing to put a Cure Putter into play each week. The success continued this past weekend, as Samuel Del Val (pictured on the far right) finished off a very successful season on the PGA TOUR LatinoAmerica with his Cure RX3. He captured seven Top-10 Finishes, including a 1st Place Finish at the Argentina Classic a few weeks back. Del Val went on to win the Zurich Argentina Swing and Finish 5th on the Money List and has advanced to play on the Web.com Tour with a full exemption for the 2017 season.
“We’d like to congratulate Sam on a great season and wish him all the best as he advances to the Web.com Tour,” said Jim McCarthy, CEO of Cure Putters. “We’re thrilled to have him rolling a Cure putter and look forward to following his continued success in 2017. Sam is an incredibly talented player and I’m sure we’ll be watching him on the PGA TOUR before too long.”
This past weekend, Samuel Del Val captured his 1st victory on the PGA TOUR Latinoamerica at the Argentina Classic presented by NEC.
Samuel Del Val birdied 17 and then rolled in a par saving 18 footer with his Cure RX3 putter to clinch his first victory in four seasons on the Tour. Del Val, who posted rounds of 69-66-68, secured the title with a score of 13-under 203. Del Val moved up to #4 on the money list and is in a good position to gain full exemption on the Web.com Tour for next season.
"This is a long-awaited victory. I've been seeking this win for four years and it's finally here," said the champion who had had two runner-up finishes in 58 previous starts thru four seasons in Latin America. Del Val became the first European champion on PGA TOUR Latinoamérica while being one of the most consistent players this season with seven Top10's in 16 starts.
"I had been working very hard for a result like this. I knew the win was there, but we know how hard this Tour is getting every year. The competition is getting so much stronger, so winning is really hard. I had been close a few times and I wasn't able to win until this week and now things are looking a lot better."
Del Val was interviewed for PGATOUR.com following his victory, watch video here: youtu.be/kKOnCYrkQnU
"We'd like to congratulate Samuel on his big win! It's a tremendous accomplishment to get your first win on tour and we're thrilled to have him rolling a Cure putter. It's been very exciting for us to follow his success this year and we wish him all the best," said Jim McCarthy, CEO of Cure Putters.